@article{ref1,
title="SNRI-NaSSA combination therapy for treatment-resistant depression",
journal="Progress in neurology and psychiatry (2007)",
year="2010",
author="Pandarakalam, J.P.",
volume="14",
number="1",
pages="26-29",
abstract="Although more quality research is required to inform clinical practice, serotonin-noradrenaline reuptake inhibitor - noradrenaline and specific serotonergic antidepressant (SNRI-NaSSA) combination therapy shows promise for treatment-resistant depression. Here, Dr Pandarakalam discusses the rationale behind the use of this combination and some of the evidence gained so far for its efficacy.<p /><p>Language: en</p>",
language="en",
issn="1931-227X",
doi="10.1002/pnp.153",
url="http://dx.doi.org/10.1002/pnp.153"
}